S. Galpin

发表

Nucleoside analogues previously found to be inactive against HIV may be activated by simple chemical phosphorylation

D. Jeffries, C. Mcguigan, D. Kinchington, 1993, FEBS letters.

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

S. Sherlock, A. Lok, H. Thomas, 1985, Gut.

Antiviral Properties of the HIV-1 Proteinase Inhibitor RO 31-8959

D. Jeffries, N. Roberts, D. Kinchington, 1994 .

A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.

J. Jaroszewski, J. Cohen, D. Kinchington, 1992, Antiviral research.

Comparative quantification of diverse serotypes of HIV‐1 in plasma from a diverse population of patients

J. Weber, R. Russell, M. Mcclure, 2000, Journal of medical virology.

Temperature enhancement of syncytium formation by HIV and sendai virus

D. Kinchington, S. Galpin, K. Apostolov, 1992, Journal of medical virology.

A randomized double‐blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV‐infected children: the PENTA‐4 trial

S. Galpin, C. Stainsby, P. Pietrosemoli, 1998 .

Synthesis and Evaluation of Some Novel Phosphoramidate Derivatives of 3′-Azido-3′-Deoxythymidine (AZT) as Anti-HIV Compounds

D. Jeffries, C. Mcguigan, K. G. Devine, 1990 .

Syncytia formation in HIV‐1 infected cells is associated with an increase in cellular oleic acid

N. Habib, C. Wood, D. Kinchington, 1989, FEBS letters.

Rational design of peptide-based HIV proteinase inhibitors.

I B Duncan, J. Kay, D. Taylor, 1990, Science.

Cyclosporin A

Jonathan Weber, Sarah Galpin, S. Galpin, 1995, Nature.

Clinical evaluation of a monoclonal assay for hepatitis B surface antigen:Identification of “HBsAg‐like” polypeptides non‐reactive in conventional radioimmunoassays

A. Lok, P. Karayiannis, H. Thomas, 1985, Journal of medical virology.

Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide.

J Waters, M Pignatelli, S Galpin, 1986, The Journal of general virology.

Clinical trial Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

P. Karayiannis, I. Weller, S. Galpin, 2006 .

Perinatal transmission of hepatitis B virus in Kenya: Its relation to the presence of serum HBV‐DNA and Anti‐HBe in the mother

P. Tukei, P. Karayiannis, H. Thomas, 1986, Journal of medical virology.

The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyte

P. Karayiannis, H. Thomas, S. Galpin, 1984, Journal of medical virology.

Aetiology of acute sporadic hepatitis in adults in kenya

P. Tukei, M. V. Shah, P. Karayiannis, 1984, Journal of medical virology.

Thomas Methods PATIENTS Between August 1980 and November 1981 , all patients who had been HBsAg and HBeAg positive for more than six months attending the Department of Medicine at the Royal Free

S. Sherlock, H. Thomas, A. Mindel, 2022 .

28 Kinase bypass: A new strategy for antl-HIV drug design

D. Jeffries, C. Mcguigan, D. Kinchington, 1993 .

Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir.

J. Weber, H. Jacobsen, J. Mous, 1997, The Journal of antimicrobial chemotherapy.

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

K. Ariyoshi, J. Weber, M. Mcclure, 2001, AIDS.

Association between a defective CCR-5 gene and progression to disease in HIV infection.

P. Easterbrook, J. McKeating, R. Daniels, 1998, AIDS research and human retroviruses.

Comparison of antigen capture assays against HIV-1 in evaluating antiviral compounds.

D. Jeffries, J. Williamson, D. Kinchington, 1989, AIDS.

Performance of two commercially available sequence‐based HIV‐1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes

J. Weber, S. Beddows, M. Mcclure, 2003, Journal of medical virology.

The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients.

B. Larder, S. Bloor, J. Weber, 1999, AIDS research and human retroviruses.